Molecular Genetic and Pathological Studies of Anal Tumors
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00267787 |
Recruitment Status
: Unknown
Verified July 2012 by Stanford University.
Recruitment status was: Recruiting
First Posted
: December 21, 2005
Last Update Posted
: July 9, 2012
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment |
---|---|
Rectal Cancer Colon Cancer Colonic Neoplasms Anal Cancer | Other: genetic analysis |
Study Type : | Observational |
Estimated Enrollment : | 300 participants |
Observational Model: | Case-Only |
Time Perspective: | Prospective |
Official Title: | Molecular Genetic and Pathological Studies of Anal Tumors |
Study Start Date : | September 2004 |
Estimated Primary Completion Date : | December 2012 |
Estimated Study Completion Date : | December 2013 |

-
Other: genetic analysis
- Genetic analysis of blood sample as well as tissues , will provide us with any possible tumor marker for a better prognostic indicator. [ Time Frame: Annual assessment. ]
Biospecimen Retention: Samples With DNA

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Senior) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:Inclusion Criteria:
- Patients with anal tumors
- Undergoing surgery for elective colon and rectal surgery
Exclusion Criteria:No other patients other than adult patients with anal cancer or high risk for anal cancer refered to Stanford will be enrolled to the study. No Children will be included to the study

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00267787
Contact: Moe Jalali | (650) 724-4023 | moej@stanford.edu |
United States, California | |
Stanford University School of Medicine | Recruiting |
Stanford, California, United States, 94305 | |
Contact: Moe Jalali 650-724-4023 moej@stanford.edu | |
Contact: Cancer Clinical Trials Office (650) 498-7061 | |
Principal Investigator: Mark Lane Welton | |
Sub-Investigator: Nader Pourmand | |
Sub-Investigator: Dr Andrew Shelton | |
Sub-Investigator: George Albert Fisher M.D. Ph.D. | |
Sub-Investigator: James M Ford | |
Sub-Investigator: Hanlee P. Ji |
Principal Investigator: | Mark Lane Welton | Stanford University |
Responsible Party: | Stanford University |
ClinicalTrials.gov Identifier: | NCT00267787 History of Changes |
Other Study ID Numbers: |
ANAL0001 95340 ( Other Identifier: Stanford University Alternate IRB Approval Number ) ANAL0001 ( Other Identifier: Stanford University ) |
First Posted: | December 21, 2005 Key Record Dates |
Last Update Posted: | July 9, 2012 |
Last Verified: | July 2012 |
Additional relevant MeSH terms:
Anus Neoplasms Colonic Neoplasms Rectal Neoplasms Colorectal Neoplasms Intestinal Neoplasms Gastrointestinal Neoplasms Digestive System Neoplasms Neoplasms by Site |
Neoplasms Digestive System Diseases Gastrointestinal Diseases Intestinal Diseases Anus Diseases Rectal Diseases Colonic Diseases |